Resources

The World Health Organization (WHO) includes 21 neglected tropical diseases (NTDs) in its 2030 road map to prevent, control, eliminate or eradicate disease. As part of this road map, more than 40 countries will be in their post–verification or validation phase for at least one disease in the next three years, including 4 for onchocerciasis, 17 for lymphatic filariasis, and 33 for trachoma.Given that disease–specific funding is likely to decrease after a country attains elimination, this presents a critical window to identify and invest in post – validation or verification surveillance (PVS) systems.One approach to improving the sustainability of PVS is to integrate surveillance with other existing surveillance platforms, or to develop new integrated platforms that share resources. Under WHO leadership and with funding from the Bill & Melinda Gates Foundation, PATH is supporting the design of an integrated PVS planning toolkit to assist national NTD programs in assessing options for sustainable and integrated approaches to NTD surveillance after elimination has been verified or validated.To guide the toolkit development, PATH conducted landscaping activities to review existing NTD surveillance platforms and strategies, with an initial focus on lymphatic filariasis, onchocerciasis, and trachoma. This landscaping report details the findings of those activities, including a literature review, semi–structured stakeholder interviews, and a toolkit review.The list of tools and toolkits reviewed and relevant findings from the review are captured in annex 1, including the disease focus, geographic focus, recommended tools or approaches, format, audience, approach, potential relevance to the integrated NTD PVS planning toolkit, and limitations.

The HIV response has pioneered integrated person–centered health services—an approach to health services that puts people and communities at the center of health systems, and empowers people to take charge of their own health rather than being passive recipients of care.Now, as countries prioritize primary health care as the foundation for achieving Universal Health Coverage (UHC), experts recommend expanding HIV–related integrated care, within HIV service platforms and in broader primary health care, to strengthen the HIV response and bring the world closer to ending AIDS as a public health threat.An integrated person–centered care (IPCC) approach is essential for several reasons. Not only can IPCC enable superior care, but it can also accelerate momentum towards UHC by removing deterrents to service access and utilization, especially among populations that have historically been marginalized and left out of mainstream healthcare.By tailoring health services to the needs and circumstances of individual people, families, and communities, IPCC seeks to motivate people to seek care, keep people engaged in care, and ensure the best possible health outcomes.Following through on the commitment to end AIDS can help unearth broader lessons from the HIV response to inform person–centered health systems that drive health for all. This report, co–published by Friends of the Global Fight, PATH, and JSI, identifies key lessons learned from the HIV response, offers future recommendations to help chart a way forward toward broader implementation of IPCC, and concludes with an action plan highlighting critical next steps that need to be taken to scale IPCC.

India faced substantial challenges amid the COVID–19 pandemic, when navigating multiple waves that strained the health care system, affecting millions. In response, the STAR 3ACP project in India, led by PSI and implemented in collaboration with PATH, Jhpiego, International Labour Organization, and with technical oversight from the WHO, addressed COVID–19 challenges through evidence generation, supply chain strengthening, policy development, and demand creation. This factsheet outlines the key activities and outcomes, emphasizing the country's pandemic response and enhanced preparedness for future health emergencies.

This retrospective observational study is among the first to assess the impact of neonicotinoid-based indoor residual spraying on malaria case incidence. (In French)

This briefing paper describes a study to assess the current and planned state of vaccine manufacturing capacity in Africa, and provides insights into what is needed to develop a robust and sustainable vaccine manufacturing ecosystem.African vaccine manufacturing is set to expand dramatically as the continent works to safeguard itself against future pandemics and disease outbreaks—but with so many new projects on the horizon, a clear picture of gaps and needs is necessary to ensure all stakeholders are aligned and investments can succeed.This research can help stakeholders, governments, and funders better coordinate and prioritize development efforts, interventions, and investments.